Clever Leaves Holdings Inc. CLVR CLVRW, a prominent global medical cannabis company, has inked a game-changing alliance with the renowned Dutch seed bank, Paradise Seeds, sparking hopes for the future of Colombia’s budding weed industry.
The strategic partnership aims to cultivate and register high-performance cannabis cultivars in Colombia. Clever Leaves will hold an exclusive license to cultivate selected genetics, while Paradise Seeds will make other cultivars accessible to third parties across Colombia and Latin America, thus entwining the fates of these two powerhouses in the fertile fields of Colombian cannabis.
Andrés Fajardo, CEO of Clever Leaves, hailed the partnership as a means to expand the company’s global footprint by fortifying its portfolio with Paradise’s award-winning strains; his counterpart, Luc Krol, founder and CEO of Paradise Seeds, radiated enthusiasm for the collaboration, citing Colombia’s favorable conditions for medical cannabis production and the strategic opportunity it presents to make Paradise varieties globally accessible.
Avicanna’s Milestone With Trunerox
Meanwhile, further igniting hopes, Toronto-based biopharmaceutical company Avicanna Inc. AVCN AVCNF celebrated a remarkable achievement with the first indication-specific drug registration for Trunerox by INVIMA, Colombia’s health authority.
This groundbreaking approval empowers Avicanna to manufacture and commercialize Trunerox in Colombia for treating seizures associated with Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (DS). CEO Aras Azadian emphasized the approval as a major leap toward serving patients with unmet medical needs, marking a pivotal moment in the fight against these debilitating conditions.
Legislative Setbacks In Cannabis Regulation
Unfortunately, amidst these heady milestones, dark clouds loomed as the Colombian Congress vetoed a bill aimed at regulating adult use and commercialization of cannabis. This setback reflects deep divisions within the legislative body and the weighty implications for Colombia’s budding cannabis industry.
Despite the support from some lawmakers advocating for regulated legalization to combat drug trafficking and protect youth, the move to shelve the bill garnered sufficient backing, led by opposition figures who viewed the measure as a capitulation to narcotrafficking interests, casting a pall over the efforts to bring the cannabis industry into the light of legality.
President Gustavo Petro minced no words in criticizing the Senate’s decision, lamenting its potential boon to the illegal drug trade and its contribution to the festering specter of violence in Colombia.
Impact on Cannabis Companies
The developments in Colombia’s cannabis industry and regulatory landscape bear significant implications for companies invested in the country’s fertile cannabis fields.
Clever Leaves Holdings Inc. CLVR CLVRW, PharmaCielo Ltd PCLOF, and Khiron Life Sciences Corp KHRNF are vigilantly monitoring these changes, recognizing the potential impact on the cultivation, production, and commercialization of cannabis products in Colombia and beyond, navigating the stormy seas of regulatory uncertainty.
As the debate over cannabis regulation continues, industry experts are keenly observing for opportunities and challenges in Colombia’s evolving market. International companies stand poised to have a hand in shaping the future of medicinal and potentially recreational cannabis in the region, navigating through the dense underbrush of regulatory measures and societal concerns.
Benzinga Cannabis Conferences are coming to Los Angeles. Join the Benzinga Cannabis Market Spotlight: California, and unlock the future of cannabis at the premier networking event in Culver City on February 22. Connect with top industry leaders, gain insider insights into the investment landscape, and shape the evolving markets in California and beyond. Don’t miss this chance to be at the forefront of the cannabis industry’s growth and innovation! Join now.
Photo: AI-Generated Image.
